Russia’s Covid Vaccine Shows Potential in Peer Review, Lancet Reports.
According to a Bloomberg Article, Russia’s proposed Covid-19 vaccine induced an antibody response in all participants in early trials and found no serious adverse effects, according to the first vetted data on the controversial project.